Literature DB >> 21208777

Randomized controlled trials of herbal interventions underreport important details of the intervention.

Joel J Gagnier1, David Moher, Heather Boon, Joseph Beyene, Claire Bombardier.   

Abstract

OBJECTIVE: To examine the quality of reporting and predictors of reporting in randomized clinical trials (RCTs) of herbal medicine interventions. STUDY DESIGN AND
SETTING: We searched Medical Literature Analysis and Retrieval System Online, Excerpta Medica Database, and Academy of Microscope Enhanced Dentistry up to December 2007 for any English language RCT of 11 commonly used herbal medicine interventions. Two individuals separately and independently assessed all trials using the Consolidated Standards of Reporting Trials (CONSORT) checklist for herbal medicines interventions. We randomly selected 100 of these trials, extracted a set of potential predictor variables identified through a literature search and consultation with experts, and performed a conceptually driven stepwise elimination regression analyses for predictor variables.
RESULTS: The 406 trials reported on average 38% of the information suggested in the checklist. Regression analyses revealed better overall reporting in trials with a participant flow diagram (P=0.008), those of Panax quinquefolius (P=0.018), and those published in more recent years (P=0.02).
CONCLUSION: Our results indicate that RCTs of herbal medicine interventions frequently do not report important characteristics of the intervention. Trialists should refer to the CONSORT for herbal medicines when reporting their trials.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21208777     DOI: 10.1016/j.jclinepi.2010.10.005

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  5 in total

Review 1.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

2.  Herbal medicinal products or preparations for neuropathic pain.

Authors:  Adele Boyd; Chris Bleakley; Deirdre A Hurley; Chris Gill; Mary Hannon-Fletcher; Pamela Bell; Suzanne McDonough
Journal:  Cochrane Database Syst Rev       Date:  2019-04-02

3.  Improving natural product research translation: From source to clinical trial.

Authors:  Barbara C Sorkin; Adam J Kuszak; Gregory Bloss; Naomi K Fukagawa; Freddie Ann Hoffman; Mahtab Jafari; Bruce Barrett; Paula N Brown; Frederic D Bushman; Steven J Casper; Floyd H Chilton; Christopher S Coffey; Mario G Ferruzzi; D Craig Hopp; Mairead Kiely; Daniel Lakens; John B MacMillan; David O Meltzer; Marco Pahor; Jeffrey Paul; Kathleen Pritchett-Corning; Sara K Quinney; Barbara Rehermann; Kenneth D R Setchell; Nisha S Sipes; Jacqueline M Stephens; D Lansing Taylor; Hervé Tiriac; Michael A Walters; Dan Xi; Giovanna Zappalá; Guido F Pauli
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.834

Review 4.  Unproven Therapies for Diabetes and Their Implications.

Authors:  Jothydev Kesavadev; Banshi Saboo; Shaukat Sadikot; Ashok Kumar Das; Shashank Joshi; Rajeev Chawla; Hemant Thacker; Arun Shankar; Lakshmy Ramachandran; Sanjay Kalra
Journal:  Adv Ther       Date:  2016-11-18       Impact factor: 3.845

5.  Are shared decision making studies well enough described to be replicated? Secondary analysis of a Cochrane systematic review.

Authors:  Titilayo Tatiana Agbadjé; Paula Riganti; Évèhouénou Lionel Adisso; Rhéda Adekpedjou; Alexandrine Boucher; Andressa Teoli Nunciaroni; Juan Victor Ariel Franco; Maria Victoria Ruiz Yanzi; France Légaré
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.